Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa: a retrospective cohort study. (2023)
Attributed to:
Addressing challenges in scaling up TB and HIV treatment integration in public health settings in South Africa
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.07.07.23292347
PubMed Identifier: 37461582
Publication URI: http://europepmc.org/abstract/MED/37461582
Type: Journal Article/Review
Parent Publication: medRxiv : the preprint server for health sciences